Pharmaceutical CEO Leadership: Diversity in Pharma - Patient Diversity

Published on: January 8, 2021

In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel relate the importance of understanding the communities they serve in order to be truly patient-centric. This includes building trust and respect with those communities, being transparent, and staying abreast of changing demographics. Rethinking trial design to be more inclusive and mirroring the diversity of these communities internally is also essential.